Relation between bladder cancer and protein oxidation

International Urology and Nephrology

Volumn 35, Issue 3, 2003, Pages 345-350

  Yilmaz, Ilker A ^a,c   Akçay, Tülay ^a   Çakatay, Ufuk ^b   Telci, Ayşegül ^b   Ataus, Süleyman ^a   Yalçin, Veli ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Bladder cancer; Carbonyl groups; Nitrotyrosine; Protein oxidation; Thiol groups

Indexed keywords

3 NITROTYROSINE; LIPID HYDROPEROXIDE; PLASMA PROTEIN; THIOL; 3-NITROTYROSINE; DRUG DERIVATIVE; IRON; THIOL DERIVATIVE; TUMOR MARKER; TYROSINE;

ADULT; ARTICLE; BLADDER CANCER; CANCER INVASION; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; LIPID PEROXIDATION; MALE; PROTEIN METABOLISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; AGED; ANALYSIS OF VARIANCE; BLADDER TUMOR; BLOOD; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; PROBABILITY; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA;

AGED; ANALYSIS OF VARIANCE; BLOOD PROTEINS; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; HUMANS; IRON; LIPID PEROXIDATION; MALE; MIDDLE AGED; NEOPLASM STAGING; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SULFHYDRYL COMPOUNDS; TUMOR MARKERS, BIOLOGICAL; TYROSINE; URINARY BLADDER NEOPLASMS;

EID: 3042766288     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:UROL.0000022920.93994.ba     Document Type: Article

References (26)

1. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. European Journal of Cancer 1996; 32A: 30-38.
2. Ross RK, Jones PA, Yu MC. Bladder cancer epidemiology and pathogenesis. Seminars in Oncology 1996; 23: 536-545.
3. Butterfield DA, Koppal T, Howard B, Subramaniam R, Hall N, Hensley K, Yatin S, Allen K, Aksenov M, Aksenova M, Carney J. Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-ter-t-butyl-alpha-phenylnitrone and vitamin E. Annals of the New York Academy of Sciences 1998; 854: 448-462.
4. Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochemical Journal 1997; 324: 1-18.
5. Stadtman ER. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radical Biology and Medicine 1990; 9: 315-325.
6. Esterbauer H, Zollner H. Methods for determination of aldehydic lipid peroxidation products. Free Radical Biology and Medicine 1989; 7: 197-203.
7. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Letters 1994; 350: 9-12.
8. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Letters 1997; 411: 157-160.
9. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods in Enzymology 1994; 233: 357-363.
10. Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods in Enzymology 1994; 233: 380-385.
11. Wolff S. Ferrous Ion Oxidation in Presence of Ferric Ion Indicator Xylenol Orange for Measurement of Hydroperoxides. Methods in Enzymology 1994; 233: 182-189.
12. Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. The Journal of Biological Chemistry 1997; 272: 20313-20316.
13. Kadlubar FF, Butler MA, Kaderlik KR, Chou HC, Lang NP. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environmental Health Perspectives 1992; 98: 69-74.
14. Popadiuk S, Korzon M, Renke J, Wozniak M. Carbonyl groups content on the basis of protein peroxidation analysis with total antioxidant status in blood of children with cancers. Wiadomosci Lekarskie 1998; 51: 107-112.
15. Pignatelli B, Li CQ, Boffetta P, Chen Q, Ahrens W, Nyberg F, Mukeria A, Bruske-Hohlfeld I, Fortes C, Constantinescu V, Ischiropoulos H, Ohshima H. Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Research 2001; 61: 778-784.
16. della Rovere F, Granata A, Saija A, Broccio M, Tomaino A, Zirilli A, De Caridi G, Broccio G. -SH groups and glutathione in cancer patient's blood. Anticancer Research 2000; 20: 1595-1598.
17. Beutler E, Gelbart T. Plasma glutathione in health and in patients with malignant disease. Journal of Laboratory and Clinical Medicine 1985; 105: 581-584.
18. Türkmen S, Afrasyap L, Güvenen G, Aldemir M. Selim ve habis meme hastalpppnda entrosit glutatyon düzeyleri ve glutatyon ilipkili enzim aktiviteleri Türk Onkoloji Dergisi 1996; 11: 30-33.
19. Davies KJ. Protein damage and degradation by oxygen radicals. I. general aspects. Journal of Biological Chemistry 1987; 262: 9895-9901.
20. Davies KJ, Delsignore ME, Lin SW. Protein damage and degradation by oxygen radicals. II. Modification of amino acids. Journal of Biological Chemistry 1987; 262: 9902-9907.
21. Davies KJ, Lin SW, Pacifici RE. Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein. Journal of Biological Chemistry 1987; 262: 9914-9920.
22. Hack V, Breitkreutz R, Kinscherf R, Rohrer H, Bartsch P, Taut F, Benner A, Droge W. The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention. Blood 1998; 92: 59-67.
23. Ushmorov A, Hack V, Droge W. Differential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexia. Cancer Research 1999; 59: 3527-3534.
24. Sheela S, Barrett JC. Degradation of type IV collagen by neoplastic human skin fibroblasts. Carcinogenesis 1985; 6: 173-179.
25. Wolf H, Haeckel C, Roessner A. Inducible nitric oxide synthase expression in human urinary bladder cancer. Virchows Archiv 2000; 437: 662-666.
26. Morcos E, Jansson OT, Adolfsson J, Kratz G, Wiklund NP. Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines. Urology 1999; 53: 1252-1257.